Because No One is Immune to the Law
February 07, 2024 - United States, Regulatory, Antitrust, FDA

2024 Regulatory, Compliance, and Enforcement Predictions for Life Sciences Companies

MoFo Life Sciences

The year 2023 was a busy one for regulatory, compliance, and enforcement developments in the healthcare and life sciences industries, and 2024 promises to be even busier. We tapped MoFo’s Life Sciences + Healthcare Compliance and Enforcement Group for a 2024 preview, and here is what our team of former government officials from the U.S. Department of Justice (DOJ), Food and Drug Administration (FDA), and Department of Health and Human Services (HHS), former in-house compliance counsel, privacy lawyers, and veteran defense attorneys have offered up.

Read the full client alert.